Filing Details
- Accession Number:
- 0001645627-17-000046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-27 13:24:28
- Reporting Period:
- 2017-04-26
- Filing Date:
- 2017-04-27
- Accepted Time:
- 2017-04-27 13:24:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,396,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,397,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,398,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,399,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,400,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,401,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,402,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,403,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.08 | 20,404,949 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 500 | $0.07 | 20,405,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,406,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,407,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,408,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,409,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,410,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,411,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,412,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,413,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,414,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,415,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,416,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,417,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,418,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,419,449 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-26 | 1,000 | $0.07 | 20,420,449 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |